Dover Corporation (DOV) vs West Pharmaceutical Services, Inc. (WST)
A side-by-side comparison of Dover Corporation and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: DOV is classified in Industrials; WST is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
DOV
Dover Corporation
$203.08IndustrialsDelayed quote: Jul 28, 2026, 4:00 PM EDT
WST
West Pharmaceutical Services, Inc.
$337.00HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — DOV vs WST
growth of $100 · dividends reinvested · last 30yDOV +2287.5%WST +8068.3%WST compounded faster
DOV WST
DOV vs WST: by the numbers
- •DOV is the larger company ($27.35B vs $23.72B market cap).
- •DOV trades at the lower trailing earnings multiple (24.86 vs 42.36 P/E), one valuation lens rather than an overall verdict.
- •WST converts more revenue to profit (16.98% vs 13.48% net margin).
- •WST grew revenue faster over the past five years (5.68% vs 2.54% CAGR).
- •DOV pays the higher dividend yield (1.01% vs 0.26%).
Metrics side by side
Valuation
| Metric | DOV | WST |
|---|---|---|
| P/E ratio | 24.86 | 42.36 |
| Forward P/E | 19.27 | 37.06 |
| P/S ratio | 3.31 | 7.10 |
| P/B ratio | 3.62 | 7.90 |
| PEG ratio | 2.27 | 33.99 |
| EV / EBITDA | 17.14 | 28.61 |
| FCF yield | 4.21% | 1.85% |
Profitability
| Metric | DOV | WST |
|---|---|---|
| Gross margin | 39.58% | 36.77% |
| Operating margin | 16.87% | 20.64% |
| Net margin | 13.48% | 16.98% |
| ROE | 14.73% | 18.89% |
| ROIC | 9.40% | 13.62% |
Dividends
| Metric | DOV | WST |
|---|---|---|
| Dividend yield | 1.01% | 0.26% |
| Payout ratio | 26.10% | 12.74% |
Growth (annualized)
| Metric | DOV | WST |
|---|---|---|
| Revenue CAGR (5Y) | 2.54% | 5.68% |
| EPS CAGR (5Y) | 10.95% | 7.85% |
| FCF CAGR (5Y) | 2.56% | 8.74% |
| Total return CAGR (5Y) | 6.04% | -2.26% |
Frequently asked
- Which has the lower trailing P/E, DOV or WST?
- DOV has the lower trailing P/E: DOV trades at 24.86 and WST at 42.36. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, DOV or WST?
- Over the past five years, WST grew revenue faster — DOV at a 2.54% CAGR versus WST at 5.68%.
- Does DOV or WST pay a bigger dividend?
- DOV yields 1.01% and WST yields 0.26% based on trailing dividends and the latest price.
- Is DOV or WST more profitable?
- WST runs the higher net margin — DOV at 13.48% versus WST at 16.98%.
- How have DOV and WST total returns compared?
- Over the past 10 years, DOV delivered 15.37% and WST delivered 15.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Dover P/E ratioWest Pharmaceutical Services P/E ratioDover dividend yieldWest Pharmaceutical Services dividend yieldDover ROEWest Pharmaceutical Services ROEDover operating marginWest Pharmaceutical Services operating marginDover revenue growthWest Pharmaceutical Services revenue growthDover free cash flowWest Pharmaceutical Services free cash flow
Dover & West Pharmaceutical Services appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.